An update from Roche Bobois SAS ( ($FR:RBO) ) is now available. Roche Bobois has reported its voting rights information as of January 31, 2025, ...
Designer Eric Hughes brings warmth to these sprawling industrial spaces—and now you never know who might turn up.
In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...